Unexplained Metabolic Acidosis: Alcoholic Ketoacidosis or Propylene Glycol Toxicity.


Journal

Journal of medical toxicology : official journal of the American College of Medical Toxicology
ISSN: 1937-6995
Titre abrégé: J Med Toxicol
Pays: United States
ID NLM: 101284598

Informations de publication

Date de publication:
04 2022
Historique:
received: 21 10 2021
accepted: 23 12 2021
revised: 15 12 2021
pubmed: 20 1 2022
medline: 13 4 2022
entrez: 19 1 2022
Statut: ppublish

Résumé

Severe metabolic acidosis with elevated anion and osmol gap is suggestive of toxic alcohol ingestion. The absence of detectable methanol or ethylene glycol in the serum could mean that metabolism is complete or that other hypotheses have to be considered. Ingestion of less common alcohol or alcoholic ketoacidosis should be investigated as illustrated by the present observation. A 46-year-old woman was admitted with altered consciousness in the Emergency Department. In the presence of a high anion gap (peak value 39 mEq/L) metabolic acidosis with mildly increased osmol gap (peak value 19 mOsm/kg), there was a high suspicion of toxic alcohol ingestion in an individual with alcohol use disorder (AUD). Serum arterial lactate concentration was particularly high at 27 mmol/L. Urinalysis failed to reveal the presence of ketone bodies or oxalate crystals. The results of the serum determination of ethanol, methanol, ethylene glycol, and isopropanol were obtained within 2 h and were negative. Due to the severity of lactic metabolic acidosis and the persisting suspicion of intoxication by a less common toxic alcohol, antidotal therapy with ethanol was initiated together with hemodialysis. Correction of lactic metabolic acidosis was obtained. Results of urinalysis obtained later revealed the presence not only of propylene glycol and D-lactate but also of significant concentrations of ß-hydroxybutyrate as a marker of alcoholic ketoacidosis. The combination of propylene glycol ingestion and alcoholic ketoacidosis may have contributed to the severity of lactic acidosis.

Identifiants

pubmed: 35043364
doi: 10.1007/s13181-022-00876-5
pii: 10.1007/s13181-022-00876-5
pmc: PMC8938525
doi:

Substances chimiques

Lactic Acid 33X04XA5AT
Ethanol 3K9958V90M
Propylene Glycol 6DC9Q167V3
Ethylene Glycol FC72KVT52F
Methanol Y4S76JWI15

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

155-158

Informations de copyright

© 2022. American College of Medical Toxicology.

Références

Ann Intern Med. 1990 Oct 15;113(8):580-2
pubmed: 2400167
Crit Care Med. 2004 Aug;32(8):1709-14
pubmed: 15286548
Clin J Am Soc Nephrol. 2008 Jan;3(1):208-25
pubmed: 18045860
Semin Dial. 2007 May-Jun;20(3):217-9
pubmed: 17555487
Pharmacotherapy. 2006 Jan;26(1):23-33
pubmed: 16422667
Intensive Care Med. 2002 Jan;28(1):81-4
pubmed: 11819005
Clin Toxicol (Phila). 2021 Aug;59(8):715-720
pubmed: 33475435
J Intern Med. 2000 Dec;248(6):511-7
pubmed: 11155144
South Med J. 2003 Sep;96(9):923-5
pubmed: 14513993
Clin Toxicol (Phila). 2016 Jun;54(5):462-3
pubmed: 27023727
J Toxicol Clin Toxicol. 2002;40(4):513-6
pubmed: 12217005
J Toxicol Clin Toxicol. 2004;42(2):163-9
pubmed: 15214621

Auteurs

Fanny de Landsheere (F)

Department of Intensive Care, Cliniques St-Luc, Université Catholique de Louvain, 1200, Brussels, Belgium.

Franck Saint-Marcoux (F)

Service de Pharmacologie, Toxicologie Et Pharmacovigilance, CHU de Limoges, 87042, Limoges, France.

Vincent Haufroid (V)

Department of Clinical Chemistry, Cliniques St-Luc, Université Catholique de Louvain, 1200, Brussels, Belgium.
Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Université Catholique de Louvain, 1200, Brussels, Belgium.

Sylvain Dulaurent (S)

Service de Pharmacologie, Toxicologie Et Pharmacovigilance, CHU de Limoges, 87042, Limoges, France.

Joseph P Dewulf (JP)

Department of Clinical Chemistry, Cliniques St-Luc, Université Catholique de Louvain, 1200, Brussels, Belgium.

Lidvine Boland (L)

Department of Clinical Chemistry, Cliniques St-Luc, Université Catholique de Louvain, 1200, Brussels, Belgium.
Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Université Catholique de Louvain, 1200, Brussels, Belgium.

Pierre-François Laterre (PF)

Department of Intensive Care, Cliniques St-Luc, Université Catholique de Louvain, 1200, Brussels, Belgium.

Philippe Hantson (P)

Department of Intensive Care, Cliniques St-Luc, Université Catholique de Louvain, 1200, Brussels, Belgium. philippe.hantson@uclouvain.be.
Louvain Centre for Toxicology and Applied Pharmacology (LTAP), Université Catholique de Louvain, 1200, Brussels, Belgium. philippe.hantson@uclouvain.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH